BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393,402 | +14.4% | 36,921 | +38.1% | 0.01% | +12.5% |
| Q2 2023 | $1,217,822 | -12.4% | 26,730 | -22.0% | 0.01% | -20.0% |
| Q1 2023 | $1,390,601 | -19.9% | 34,285 | +0.6% | 0.01% | -28.6% |
| Q4 2022 | $1,737,115 | +48.2% | 34,081 | +56.6% | 0.01% | -6.7% |
| Q3 2022 | $1,172,000 | -13.4% | 21,765 | +3.3% | 0.02% | -11.8% |
| Q2 2022 | $1,354,000 | -28.4% | 21,071 | -13.6% | 0.02% | -26.1% |
| Q1 2022 | $1,892,000 | -12.7% | 24,396 | -3.4% | 0.02% | -14.8% |
| Q4 2021 | $2,168,000 | -1.1% | 25,259 | -7.4% | 0.03% | -10.0% |
| Q3 2021 | $2,193,000 | +7.2% | 27,265 | +7.3% | 0.03% | +3.4% |
| Q2 2021 | $2,045,000 | +20.6% | 25,404 | +26.3% | 0.03% | -19.4% |
| Q1 2021 | $1,696,000 | +41.8% | 20,114 | +34.9% | 0.04% | +28.6% |
| Q4 2020 | $1,196,000 | -7.8% | 14,910 | -7.6% | 0.03% | -17.6% |
| Q3 2020 | $1,297,000 | +14.2% | 16,132 | +22.3% | 0.03% | +13.3% |
| Q2 2020 | $1,136,000 | +5.1% | 13,188 | -1.0% | 0.03% | -16.7% |
| Q1 2020 | $1,081,000 | -0.6% | 13,319 | +2.6% | 0.04% | +24.1% |
| Q4 2019 | $1,087,000 | -4.9% | 12,977 | -0.6% | 0.03% | -17.1% |
| Q3 2019 | $1,143,000 | +8.8% | 13,058 | +1.7% | 0.04% | +9.4% |
| Q2 2019 | $1,051,000 | +10.4% | 12,843 | +9.3% | 0.03% | +3.2% |
| Q1 2019 | $952,000 | +12.7% | 11,755 | -8.2% | 0.03% | -6.1% |
| Q4 2018 | $845,000 | -36.1% | 12,811 | -25.4% | 0.03% | -28.3% |
| Q3 2018 | $1,323,000 | +2.1% | 17,170 | -2.1% | 0.05% | -29.2% |
| Q2 2018 | $1,296,000 | +10.8% | 17,531 | -1.8% | 0.06% | +27.5% |
| Q1 2018 | $1,170,000 | -0.9% | 17,858 | -2.6% | 0.05% | +2.0% |
| Q4 2017 | $1,181,000 | -0.3% | 18,343 | -3.0% | 0.05% | -7.4% |
| Q3 2017 | $1,184,000 | +0.3% | 18,909 | -3.2% | 0.05% | -3.6% |
| Q2 2017 | $1,180,000 | +4.0% | 19,538 | -10.5% | 0.06% | +3.7% |
| Q1 2017 | $1,135,000 | +16.9% | 21,820 | -0.5% | 0.05% | +8.0% |
| Q4 2016 | $971,000 | -49.3% | 21,922 | -45.5% | 0.05% | -31.5% |
| Q3 2016 | $1,914,000 | +72.1% | 40,204 | +63.6% | 0.07% | +12.3% |
| Q2 2016 | $1,112,000 | -4.1% | 24,578 | -13.1% | 0.06% | -9.7% |
| Q1 2016 | $1,159,000 | +4.6% | 28,273 | -2.8% | 0.07% | +1.4% |
| Q4 2015 | $1,108,000 | +0.6% | 29,079 | -13.2% | 0.07% | -5.3% |
| Q3 2015 | $1,101,000 | -45.5% | 33,511 | +14.1% | 0.08% | -41.9% |
| Q2 2015 | $2,021,000 | 0.0% | 29,366 | 0.0% | 0.13% | -0.8% |
| Q1 2015 | $2,021,000 | +6.3% | 29,366 | +13.1% | 0.13% | -3.7% |
| Q4 2014 | $1,902,000 | +28.2% | 25,975 | +25.9% | 0.14% | +33.7% |
| Q3 2014 | $1,484,000 | -8.6% | 20,636 | -8.0% | 0.10% | -5.6% |
| Q2 2014 | $1,623,000 | +2.0% | 22,439 | +3.4% | 0.11% | -6.1% |
| Q1 2014 | $1,591,000 | +8.3% | 21,693 | +2.7% | 0.11% | +1.8% |
| Q4 2013 | $1,469,000 | +35.1% | 21,124 | +28.0% | 0.11% | +19.1% |
| Q3 2013 | $1,087,000 | +65.2% | 16,507 | +73.8% | 0.09% | +44.6% |
| Q2 2013 | $658,000 | -24.3% | 9,499 | -20.6% | 0.06% | -26.1% |
| Q1 2013 | $869,000 | – | 11,959 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |